XNCR

$13.01+0.16 (+1.25%)

After Hours$12.70-0.31 (-2.38%)· Last close May 6

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO